Stay updated on VIC-1911 Monotherapy + Sotorasib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the VIC-1911 Monotherapy + Sotorasib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VIC-1911 Monotherapy + Sotorasib in NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-06T09:29:57.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    1.0%
    Check dated 2025-05-30T04:29:07.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.0, replacing the previous version 2.15.2.
    Difference
    0.2%
    Check dated 2025-05-22T21:54:14.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new study involving VIC-1911 and sotorasib, with significant changes in the study's duration and assessment timelines, now focusing on a shorter 9-month period instead of the previous 42 months.
    Difference
    9%
    Check dated 2025-05-08T13:09:08.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T05:41:47.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new version of the study protocol for the VIC-1911 clinical trial, including specific details about the number of subjects anticipated in various cohorts and the removal of previous detailed descriptions of the study phases and inclusion criteria.
    Difference
    49%
    Check dated 2025-04-16T14:43:49.000Z thumbnail image

Stay in the know with updates to VIC-1911 Monotherapy + Sotorasib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VIC-1911 Monotherapy + Sotorasib in NSCLC Clinical Trial page.